| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.019 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |